S.A. Mason LLC Has $258,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

S.A. Mason LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 495 shares of the medical equipment provider’s stock after purchasing an additional 20 shares during the quarter. S.A. Mason LLC’s holdings in Intuitive Surgical were worth $258,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Consolidated Planning Corp grew its stake in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 73.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after acquiring an additional 114,149 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 over the last three months. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $571.88 on Monday. The stock has a market cap of $203.69 billion, a PE ratio of 89.22, a P/E/G ratio of 5.51 and a beta of 1.39. The firm has a 50-day moving average of $550.40 and a 200-day moving average of $509.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.